⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2443280 | 0.88 | CYP1A2 (0.38) | — | |
| SCHEMBL14322288 | 0.79 | THRA (0.36) | — | |
| SCHEMBL1698120 | 0.77 | NSD2 (0.31) | — | |
| SCHEMBL14152134 | 0.75 | — | — | |
| SCHEMBL11389339 | 0.74 | — | — | |
| SCHEMBL15693461 | 0.73 | THRA (0.33) | — | |
| SCHEMBL18567991 | 0.72 | THRA (0.32) | — | |
| SCHEMBL16823670 | 0.70 | — | — | |
| SCHEMBL16823667 | 0.70 | — | — | |
| SCHEMBL16830316 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2585569-A1 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2013-05-01 | — | — | EP | claimed |
| CN-102947432-A | Perfume system | PROCTER & GAMBLE | 2013-02-27 | — | — | CN | claimed |
| WO-2011163337-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2011-12-29 | — | — | WO | claimed |
| US-20110308555-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | claimed |
| US-20180258371-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-09-13 | — | — | US | disclosed |
| US-9994793-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2018-06-12 | — | — | US | disclosed |
| US-9994793-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2018-06-12 | — | — | US | disclosed |
| EP-3121255-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-03-28 | — | — | EP | disclosed |
| EP-3121255-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-03-28 | — | — | EP | disclosed |
| EP-3287511-A1 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2018-02-28 | — | — | EP | disclosed |
| EP-3085759-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-02-07 | — | — | EP | disclosed |
| CN-107012022-A | PERFUME SYSTEMS | 宝洁公司 | 2017-08-04 | — | — | CN | disclosed |
| US-20080090823-A1 | THIADIAZOLES AS CXC- AND CC- CHEMOKINE RECEPTOR LIGANDS | MERCK SHARP & DOHME CORP. | 2008-04-17 | — | — | US | disclosed |
| US-20070264230-A1 | Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands | SCHERING CORPORATION | 2007-11-15 | — | — | US | disclosed |
| CN-101035768-A | Compounds and compositions as cathepsin S inhibitors | NOVARTIS AG (CH) | 2007-09-12 | — | — | CN | disclosed |
| EP-1818325-A2 | 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands | SCHERING CORPORATION (US) | 2007-08-15 | — | — | EP | disclosed |
| EP-1381590-B1 | 3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR LIGANDS | SCHERING CORP (US) | 2007-06-20 | — | — | EP | disclosed |
| EP-1781623-A1 | COMPOUNDS AND COMPOSITIONS USEFUL AS CATHEPSIN S INHIBITORS | Novartis AG (CH) | 2007-05-09 | — | — | EP | disclosed |
| US-20070021494-A1 | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands | SCHERING CORPORATION AND PHARMACOPEIA, INC. | 2007-01-25 | — | — | US | disclosed |
| WO-2006018284-A1 | COMPOUNDS AND COMPOSITIONS USEFUL AS CATHEPSIN S INHIBITORS | NOVARTIS AG (CH) | 2006-02-23 | — | — | WO | disclosed |